# Kura Oncology, Inc.: Form 8-K, filed Jan 14, 2025

- Company: [Kura Oncology, Inc.](/companies/kura.md) (CIK 1422143)
- Form: 8-K
- Filed: 2025-01-14
- Accepted by EDGAR: Jan 14, 2025, 16:36 ET
- Period: 2025-01-13
- Accession: 0001193125-25-006197
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1422143/000119312525006197/d875953d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422143/000119312525006197/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422143/000119312525006197/d875953d8k.htm

Filed Jan 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-006197. Last ingested by Listed: Nov 11, 2026, 03:30 ET. No prices; not investment advice.